The company
Embecta Corp.
EMBC · Nasdaq
EMBC stood above a rising 150-day average in 6 of the last 52 weekly readings, and has been out of that trend for the last 41 weeks. It is 26.9% above that average now. Medical Devices: 29% of its 181 stocks in an uptrend (−4 points in four weeks); Health Care: 27% (−6 points in four weeks).
Statistics
- Last close, 22 Oct 2026
- 6.86 +2.69%
- 52-week range
- —
- Volume
- 0.92M
- Average volume (50 days)
- —
- Relative volume
- —
- Rotation
- Above a falling average
- Weeks in an uptrend
- out for 41
- Industry in uptrend
- 29% -4 in 4 wk
- Insider buys, 12 months
- $1.1M
- Insider sales, 12 months
- $74K
- Officials’ trades on record
- 5
- Institutions holding
- 305 (-9)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 6 of 52 weeks.
Medical Devices: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.
Price and volume
Daily bars to 22 Oct 2026: 29 sessions (1Y reaches back before the first session held here, 11 Sep 2026, so this is all of them). 1D is the last two sessions and 1W the last week of the same daily bars; nothing here is intraday.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
5 disclosed lines: House 0, Senate 0, executive 5; 1 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $1k–$15k | 15 May 2026filed 1 Jul 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $15k–$50k | 30 Apr 2026filed 1 Jul 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $15k–$50k | 30 Mar 2026filed 14 May 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $15k–$50k | 26 Feb 2026filed 14 May 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $15k–$50k | 26 Jan 2026filed 14 May 2026 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Milton Mayo MorrisDirector | sold | 6,293at $5.88 | 4 Sep 2026filed 8 Sep 2026 |
| Robert J. HombachDirector | bought | 45,000at $4.97 | 12 Aug 2026filed 13 Aug 2026 |
| Jeffrey Z. MannPres, Pharm Svc&Prod Mgmt, CLO | bought | 20,000at $4.99 | 12 Aug 2026filed 13 Aug 2026 |
| Jacob ElguiczeSVP and CFO | bought | 20,000at $4.67 | 12 Aug 2026filed 13 Aug 2026 |
| Devdatt KurdikarPresident and CEO | bought | 30,000at $4.70 | 12 Aug 2026filed 13 Aug 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| BlackRock, Inc.reduced · filed 7 Aug 2026 | 4,599,771$15.0M | -4,567,441−49.8% |
| YACKTMAN ASSET MANAGEMENT LPadded · filed 11 Aug 2026 | 4,315,952$14.1M | +644,075+17.5% |
| VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 2026 | 2,557,148$8.3M | -6,803−0.3% |
| DEERFIELD MANAGEMENT COMPANY, L.P.unchanged · filed 14 Aug 2026 | 2,534,961$8.3M | 00.0% |
| Jefferies Financial Group Inc.reduced · filed 17 Aug 2026 | 2,355,117$7.7M | -450.0% |
| AMERIPRISE FINANCIAL INCadded · filed 14 Aug 2026 | 2,038,731$6.6M | +1,239,043+154.9% |
| MORGAN STANLEYadded · filed 13 Aug 2026 | 1,996,747$6.5M | +1,386,943+227.4% |
| STATE STREET CORPreduced · filed 7 Aug 2026 | 1,610,666$5.3M | -935,307−36.7% |
| GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026 | 1,594,457$5.2M | +128,810+8.8% |
| BRIGADE CAPITAL MANAGEMENT, LPnew · filed 14 Aug 2026 | 1,516,453$4.9M | +1,516,453 |
News
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.